| Dr Bo Yon Choi, DO | |
|
4500 S Garnett Rd Ste 300, Tulsa, OK 74146-5238 | |
| (918) 728-6194 | |
| Not Available |
| Full Name | Dr Bo Yon Choi |
|---|---|
| Gender | Female |
| Speciality | Diagnostic Radiology |
| Experience | 16 Years |
| Location | 4500 S Garnett Rd Ste 300, Tulsa, Oklahoma |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1053551721 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2085R0202X | Radiology - Diagnostic Radiology | 5101017850 (Michigan) | Secondary |
| 2085R0202X | Radiology - Diagnostic Radiology | 5538 (Oklahoma) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| St Mary's Regional Medical Center | Enid, OK | Hospital |
| Cherokee Nation W W Hastings Indian Hospital | Tahlequah, OK | Hospital |
| Saint Francis Hospital Muskogee | Muskogee, OK | Hospital |
| Alliancehealth Midwest | Midwest city, OK | Hospital |
| Integris Bass Baptist Health Center | Enid, OK | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Comanche County Hospital Authority Southwest Radiology | 7113082009 | 50 |
| Creek Nation Hospital And Clinics | 5698786226 | 265 |
| Diagnostic Imaging Associates Inc | 8820083645 | 64 |
| Albuquerque Indian Health Center | 7719883164 | 46 |
| Cherokee Nation | 5799698742 | 329 |
| Choctaw Nation Of Oklahoma | 1759294838 | 204 |
| Claremore Indian Hospital | 9436069911 | 109 |
| Creek Nation Hospital And Clinics | 5698786226 | 265 |
| Lawton Indian Hospital | 6406800234 | 94 |
| Pawnee Indian Health Center | 2769470160 | 59 |
| Pine Ridge Indian Health Service Hospital | 4688571326 | 93 |
| Wewoka Indian Health | 7517911415 | 34 |
| Zuni Indian Hospital | 5698689644 | 57 |
News Archive
An appetite-suppressing chemical also improves glucose tolerance and lowers insulin levels in obese and diabetic mice, researchers report in the November issue of Cell Metabolism, a publication of Cell Press.
Johnson & Johnson today announced sales for the first quarter of $11.6 billion, an increase of 17.7% over the prior year. The increase represented operational growth of 12.3% and a currency impact of 5.4%. Domestic sales were up 15.1%, while international sales increased 21.8%, including operational growth of 7.8% and a positive currency impact of 14.0%.
Benitec has announced an exclusive licensing deal with Stanford University. Under the license, Benitec receives exclusive rights to use the Minicircle DNA technology pioneered at Stanford University for all RNAi therapeutic uses, with sub-licensing rights.
Research funded in part by the Canadian Cancer Society may lead to a genetic screening test that could help families who are at high risk for cancer.
› Verified 9 days ago
| Entity Name | Ctca Physicans Group Of Oklahoma, Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1053309591 PECOS PAC ID: 2163328774 Enrollment ID: O20031212000074 |
News Archive
An appetite-suppressing chemical also improves glucose tolerance and lowers insulin levels in obese and diabetic mice, researchers report in the November issue of Cell Metabolism, a publication of Cell Press.
Johnson & Johnson today announced sales for the first quarter of $11.6 billion, an increase of 17.7% over the prior year. The increase represented operational growth of 12.3% and a currency impact of 5.4%. Domestic sales were up 15.1%, while international sales increased 21.8%, including operational growth of 7.8% and a positive currency impact of 14.0%.
Benitec has announced an exclusive licensing deal with Stanford University. Under the license, Benitec receives exclusive rights to use the Minicircle DNA technology pioneered at Stanford University for all RNAi therapeutic uses, with sub-licensing rights.
Research funded in part by the Canadian Cancer Society may lead to a genetic screening test that could help families who are at high risk for cancer.
› Verified 9 days ago
| Entity Name | Diagnostic Imaging Associates Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1427049956 PECOS PAC ID: 8820083645 Enrollment ID: O20040420000018 |
News Archive
An appetite-suppressing chemical also improves glucose tolerance and lowers insulin levels in obese and diabetic mice, researchers report in the November issue of Cell Metabolism, a publication of Cell Press.
Johnson & Johnson today announced sales for the first quarter of $11.6 billion, an increase of 17.7% over the prior year. The increase represented operational growth of 12.3% and a currency impact of 5.4%. Domestic sales were up 15.1%, while international sales increased 21.8%, including operational growth of 7.8% and a positive currency impact of 14.0%.
Benitec has announced an exclusive licensing deal with Stanford University. Under the license, Benitec receives exclusive rights to use the Minicircle DNA technology pioneered at Stanford University for all RNAi therapeutic uses, with sub-licensing rights.
Research funded in part by the Canadian Cancer Society may lead to a genetic screening test that could help families who are at high risk for cancer.
› Verified 9 days ago
| Entity Name | Creek Nation Hospital & Clinics |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1366593923 PECOS PAC ID: 5698786226 Enrollment ID: O20070821000130 |
News Archive
An appetite-suppressing chemical also improves glucose tolerance and lowers insulin levels in obese and diabetic mice, researchers report in the November issue of Cell Metabolism, a publication of Cell Press.
Johnson & Johnson today announced sales for the first quarter of $11.6 billion, an increase of 17.7% over the prior year. The increase represented operational growth of 12.3% and a currency impact of 5.4%. Domestic sales were up 15.1%, while international sales increased 21.8%, including operational growth of 7.8% and a positive currency impact of 14.0%.
Benitec has announced an exclusive licensing deal with Stanford University. Under the license, Benitec receives exclusive rights to use the Minicircle DNA technology pioneered at Stanford University for all RNAi therapeutic uses, with sub-licensing rights.
Research funded in part by the Canadian Cancer Society may lead to a genetic screening test that could help families who are at high risk for cancer.
› Verified 9 days ago
| Entity Name | Comanche County Hospital Authority Southwest Radiology |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1194996447 PECOS PAC ID: 7113082009 Enrollment ID: O20090209000657 |
News Archive
An appetite-suppressing chemical also improves glucose tolerance and lowers insulin levels in obese and diabetic mice, researchers report in the November issue of Cell Metabolism, a publication of Cell Press.
Johnson & Johnson today announced sales for the first quarter of $11.6 billion, an increase of 17.7% over the prior year. The increase represented operational growth of 12.3% and a currency impact of 5.4%. Domestic sales were up 15.1%, while international sales increased 21.8%, including operational growth of 7.8% and a positive currency impact of 14.0%.
Benitec has announced an exclusive licensing deal with Stanford University. Under the license, Benitec receives exclusive rights to use the Minicircle DNA technology pioneered at Stanford University for all RNAi therapeutic uses, with sub-licensing rights.
Research funded in part by the Canadian Cancer Society may lead to a genetic screening test that could help families who are at high risk for cancer.
› Verified 9 days ago
| Entity Name | Genesiscare Landmark Oklahoma Cancer Care Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1952914814 PECOS PAC ID: 2567870538 Enrollment ID: O20210413001692 |
News Archive
An appetite-suppressing chemical also improves glucose tolerance and lowers insulin levels in obese and diabetic mice, researchers report in the November issue of Cell Metabolism, a publication of Cell Press.
Johnson & Johnson today announced sales for the first quarter of $11.6 billion, an increase of 17.7% over the prior year. The increase represented operational growth of 12.3% and a currency impact of 5.4%. Domestic sales were up 15.1%, while international sales increased 21.8%, including operational growth of 7.8% and a positive currency impact of 14.0%.
Benitec has announced an exclusive licensing deal with Stanford University. Under the license, Benitec receives exclusive rights to use the Minicircle DNA technology pioneered at Stanford University for all RNAi therapeutic uses, with sub-licensing rights.
Research funded in part by the Canadian Cancer Society may lead to a genetic screening test that could help families who are at high risk for cancer.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Bo Yon Choi, DO Po Box 973038, Dallas, TX 75397-3038 Ph: (918) 622-0436 | Dr Bo Yon Choi, DO 4500 S Garnett Rd Ste 300, Tulsa, OK 74146-5238 Ph: (918) 728-6194 |
News Archive
An appetite-suppressing chemical also improves glucose tolerance and lowers insulin levels in obese and diabetic mice, researchers report in the November issue of Cell Metabolism, a publication of Cell Press.
Johnson & Johnson today announced sales for the first quarter of $11.6 billion, an increase of 17.7% over the prior year. The increase represented operational growth of 12.3% and a currency impact of 5.4%. Domestic sales were up 15.1%, while international sales increased 21.8%, including operational growth of 7.8% and a positive currency impact of 14.0%.
Benitec has announced an exclusive licensing deal with Stanford University. Under the license, Benitec receives exclusive rights to use the Minicircle DNA technology pioneered at Stanford University for all RNAi therapeutic uses, with sub-licensing rights.
Research funded in part by the Canadian Cancer Society may lead to a genetic screening test that could help families who are at high risk for cancer.
› Verified 9 days ago
Jonathan Cross, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 5801 E 41st St Ste 900, Tulsa, OK 74135 Phone: 918-747-4975 Fax: 918-743-8552 | |
Dr. Kim R Hauger, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 5801 E 41st St Ste 900, Tulsa, OK 74135 Phone: 918-747-4975 Fax: 918-743-8552 | |
Nina Jones, MD Radiology Medicare: Medicare Enrolled Practice Location: 4500 S Garnett Rd Ste 300, Tulsa, OK 74146 Phone: 918-728-6194 | |
Dr. Leila Danielle See, D.O. Radiology Medicare: Accepting Medicare Assignments Practice Location: 744 W 9th St, Tulsa, OK 74127 Phone: 981-599-5031 | |
Christopher Roman, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 4500 S Garnett Rd Ste 112, Tulsa, OK 74146 Phone: 918-935-3550 | |
Dr. Phillip Osborn Flinn, M.D. Radiology Medicare: Medicare Enrolled Practice Location: 1120 S Utica Ave, Tulsa, OK 74104 Phone: 918-934-8347 Fax: 918-917-4114 | |
Shawn D Grant, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 1120 S Utica Ave, Tulsa, OK 74104 Phone: 918-579-7720 |